Resistance to m-AMSA in Human Myeloid Leukaemia
Author Information
Author(s): W.L. Skinner, D. Murray, V. Kohli, M. Beran, K.B. McCredie, E.J. Freireich, B.S. Andersson
Primary Institution: The University of Texas M.D. Anderson Cancer Center
Hypothesis
Is the decrease in m-AMSA induced DNA strand breakage a general mechanism for m-AMSA resistance in human AML?
Conclusion
The study found that the development of resistance to m-AMSA in human myeloid leukaemia involves two distinct phases, with a significant loss of a 76 kDa protein associated with high resistance.
Supporting Evidence
- The study identified two phases in the development of resistance to m-AMSA.
- Low-degree resistance was characterized by a slight decrease in DNA strand breakage.
- High-degree resistance was associated with the loss of a 76 kDa protein.
Takeaway
Researchers studied how leukemia cells become resistant to a drug called m-AMSA, finding that they go through two stages of resistance, and losing a specific protein seems to help them resist the drug.
Methodology
The study used clonogenic assays, alkaline elution, and polyacrylamide gel electrophoresis to evaluate the response of KBM-3 cell lines to m-AMSA.
Limitations
The study does not clarify whether the observed changes in protein levels are directly responsible for the development of resistance.
Participant Demographics
The cell line was established from a patient with acute myelogenous leukemia.
Want to read the original?
Access the complete publication on the publisher's website